Wnt-10b is expressed during the formation of the mammary rudiment in mouse embryos and its expression continues through puberty when the mammary ductal pattern is established under control of ovarian steroids. Recently, viral activation of the Wnt-10b locus has linked its overexpression to mammary tumor formation, suggesting a role for Wnt-10b in patterning and growth-regulation of the mammary gland. To test this notion, we created lines of transgenic mice that express elevated levels of Wnt-10b under the control of the MMTV promoter/enhancer. Overexpression of this gene resulted in profound developmental alterations in the mammary gland, including expanded glandular development and the precocious appearance of alveoli in virgin females. Moreover, transgenic male mice also exhibited dramatic mammary development involving highly branched mammary ducts and gynecomastia. Aberrant expression of Wnt-10b in the mammary rudiments of males evidently bypasses the normal requirement for ovarian hormonal control in stimulating mammary ductal growth and the repressive eects of androgens. In addition to these developmental eects, transgenic mice of both sexes were highly susceptible to the development of mammary adenocarcinomas. Such tumors arose in a solitary manner indicating that Wnt10b is a proto-oncogene which provides a necessary, but insucient signal for oncogenesis. Relevant to this, there was no evidence of ampli®ed expression of FGF mRNAs in these tumors though the Fgf's are a class of genes often implicated as collaborators in Wnt-mediated tumor formation. Indeed, co-expression of MMTV-Wnt10b and MMTV-FGF-3/int-2 resulted in sterile ospring with highly disorganized mammary epithelium, demonstrating a potent interaction between their respective developmental pathways. These results suggest that Wnt-10b, or other Wnt genes expressed early in mammary development, play a role in regulating sexual dimorphism and show potent transforming activity when overexpressed.
Introduction
Wnt genes comprise a family of secreted growth factors involved in pattern formation in vertebrate and invertebrate development (Parr and McMahon, 1994) .
A small subset of this family also appear capable of cellular transformation, as demonstrated by the frequent activation of Wnt-1 and Wnt-3 by retroviral insertion in the mammary glands of mice (Nusse and Varmus, 1982; Peters et al., 1986; Roelink et al., 1990) . However, the link between mammary transformation and the normal function of Wnt genes is not clear. Neither Wnts-1 or -3 are expressed in the mammary gland at any stage of development. Indeed, several of the Wnt genes normally expressed in mammary epithelial cells appear to have little or no transforming activity, and appear unable to recapitulate the potent transforming phenotype of Wnts-1 and -3 when expressed in mammary transplants (Wong et al., 1994; Bradbury et al., 1995) . These results indicate that the oncogenic activities of Wnts-1 and -3 are unique, and depend on inappropriate activation of a distinct receptor pathway.
Development of the mammary gland is broadly governed by ovarian and pituitary hormones (Nandi, 1958) . In addition, the patterning of mammary ducts is controlled by local factors which act at close range (Fauklin and DeOme, 1960) . Currently, there is evidence for the regulated expression of Wnts-2, -4, -5a, -5b, -6 and -7b, during various phases of mammary gland development (Gavin and McMahon, 1992; BuÈ hler et al., 1993; Weber-Hall et al., 1994) . Evidence that Wnt genes play a role in mammary gland development comes from the regulated expression of these genes in key phases of glandular development (Gavin and McMahon, 1992; Weber-Hall et al., 1994) , and from the proliferative eects of Wnt genes when overexpressed in mammary epithelial cells (Roelink et al., 1990; Wong et al., 1994; Bradbury et al., 1995) . Currently, little is known about the role of individual Wnt genes, or how these genes interact to establish the ®nal form and function of the adult mammary gland.
The Wnt-10b locus was cloned by retroviral insertional activation, similar to the strategy used to identify other mammary oncogenes (Lee et al., 1995) . The human homolog (WNT10B) has been cloned recently and is found to be expressed in a subset of breast adenocarcinomas (Bui et al., 1997a) and endometrial carcinomas (Bui et al., 1997b) . Unlike Wnt-1 and Wnt-3, Wnt-10b is expressed in untransformed mammary epithelium (Lee et al., 1995; Christiansen et al., 1995; Wang and Shackleford, 1996) . Since Wnt-10b is potentially the earliest Wnt gene expressed in mammary development (Christiansen et al., 1995) , it is positioned to play a key role in growth regulation of this gland.
Identi®cation of Wnt-10b provided the opportunity to study a Wnt gene that was both expressed in the mammary gland and had potential for endogenous transforming activity. Here we provide evidence that overexpression of Wnt-10b leads to increased branching of mammary ducts and to pronounced alveolar development, features of mammary development normally seen at pregnancy. These changes are similar to those observed in mice expressing Wnt-1 (Tsukamoto et al., 1988), a gene not normally expressed in this tissue. In addition, most parous females developed 1 ± 3 clonal adenocarcinomas within 3 ± 6 months. MMTV-Wnt-10b male mice develop feminized mammary tissues and were also prone to mammary adenocarcinoma. These results provide evidence that Wnt-10b is one of a distinct subset of Wnt-family growth factors that have high transforming potential. The similarity in phenotype with Wnt-1 overexpressing mice provides evidence that receptors normally used to transduce Wnt-10b signals might be appropriated by Wnt-1 during transformation by this gene. In addition, these results suggest that the normal role of Wnt genes is to promote branching and alveolar outgrowth of mammary ducts during puberty and pregnancy. The actions of multiple Wnt genes might provide a somewhat redundant signal that is critical to the establishment of the female pattern in this gland.
Results
Isolation of cDNA and construction of Wnt-10b transgenes cDNAs for Wnt-10b were isolated from a 17 day (d) mouse embryo cDNA library as described (Lee et al., 1995) . Three clones were identical (clones F6S, F8S, F9S) (isoform I, Figure 1a ) while a 4th (clone F4S) contained a distinct 5' untranslated region (UTR) and a truncated 3' UTR (isoform II, Figure 1a ). All four clones contained identical open reading frames. To establish the basis for the dierent 5' sequences, we sequenced a 3037 bp SacI ± EcoRI genomic fragment of mouse Wnt-10b (GenBank accession no. AF029307).
Comparison of the cDNA sequences with the genomic fragment revealed that the two 5' cDNA ends arose from alternative splicing of two untranslated exons (Figure 1b) .
Isoform I, which appeared to be the more prevalent cDNA species, contained exon 1b, followed by exon 2, the entire open reading frame of Wnt-10b (exons 2 ± 5), and a relatively long 3' untranslated sequence (unknown exon structure). Isoform II, contained exon 1a, followed by exon 2, the entire open reading frame of Wnt-10b (exons 2 ± 5), and a relatively short 3' untranslated sequence (Figure 1a ). The location of transcribed sequences 3' of exon 3 in genomic DNA was not determined. Because the ATG codon is located in exon 2, and is shared by both transcripts, both cDNAs encode identical proteins.
To verify that both isoforms of the Wnt-10b cDNA generate translatable protein, in vitro translation reactions were performed on the parent plasmids pBSKSII-F9s (isoform I) and pBSKSII-F4s (isoform II). As shown in Figure 2a , both isoform I (lane 2) and isoform II (lane 4) generated equivalent quantities of an approximately 43 kDa translation product (expected size 43.13 kDa). Addition of canine microsomal membranes (CMM) resulted in the appearance of a doublet at higher apparent molecular weight (lanes 3 and 5). This result indicates that translation products have the potential to undergo glycosylation as has been reported for other WNT proteins (Smolich et al., 1993) . Vector alone (lane 1) or an antisense clone of isoform I (lane 6) showed no speci®c protein synthesis in this assay. Figure 1 The structures of two alternatively spliced Wnt-10b cDNA isoforms and the pattern of Wnt-10b expression in mammary tissues. (a) cDNA isoform I (5' end=exon 1b) represented three of four cDNA clones studied. Isoform II (one of four) had a dierent 5' untranslated region (5' end=exon 1a) and a short 3' untranslated region. The open reading frames of both types of cDNA were identical. Probe A shows the sequences used to probe RNA blots in c. (b) a 3 kb fragment of the Wnt-10b gene was sequenced to determine the locations of intron-exon boundaries for the two alternatively utilized 5' exons (GenBank accession no. AF029307). The start of translation (ATG) is found in exon 2 and is common to both cDNA isoforms. Unique restriction sites are indicated: C, ClaI; D, DraIII; BX, BstXI; N, NotI; H, HindIII; S, SacI and RI, EcoRI. ± 3) , or by analysis of 28S ribosomal subunit by EtBr staining of the gel prior to transfer (lanes 4 ± 13) Expression of Wnt-10b mRNA in embryonic and adult tissues Our previous report demonstrated a low abundance 3.8 kb Wnt-10b mRNA in late stages of fetal development, adult mammary glands, and in tumors (Lee et al., 1995) . Mapping of the gene has now shown that the probe used in the original analysis identi®ed mRNA species containing exon 1a (isoform II). To determine the expression pattern of both isoforms in mammary tissues, we examined expression of Wnt-10b in a staged series of mammary tissues with a probe that overlapped the entire Wnt-10b open reading frame (probe A, Figure 1a) . As with the exon 1a speci®c probe, we detected a single RNA species (here identi®ed as 3.55 kb) in poly(A) + RNA isolated from virgin mammary gland tissue (Figure 1c , lanes 5 and 6). An additional 3.9 kb transcript was detected in 17d embryos (lane 1), but appeared absent from adult mammary gland. RNA was also detected in 12.5d embryonic head (lane 2) and torso (lane 3).
In adult mammary gland, the 3.55 kb Wnt-10b transcript was present in poly(A) + RNA from adolescent (5 week, Figure 1c , lane 5) and mature virgin (10 week, lane 5) mammary tissue. Transcripts decreased in early pregnancy (lane 7) and were undetectable in lactating mammary glands (lane 4). Transcript levels then recovered during post-lactational regression (lanes 9 ± 11). Loss of apparent expression during late pregnancy and lactation cannot necessarily be taken as a loss of transcription since the high levels of milk-gene RNAs dilute the signal of many regulatory genes. Transcripts were detected in cell lines derived from an MMTV-c-myc tumor (lane 13), but were absent in cells derived from an MMTV-neu tumor (lane 12). Transcripts have also been detected in several human mammary epithelial cell lines, but are absent from ®broblasts (data not shown).
Overexpression of Wnt-10b in mice
Both isoforms of Wnt-10b cDNA were subcloned into an MMTV promoter construct (Figure 2b ) which has been shown to target expression to the mammary gland of transgenic mice (Muller et al., 1988) . Three independent transgenic lines were derived from transgene 1 (isoform I, lines WA, WB, and WC). All expressed high levels of transgene mRNA (not shown). Conversely, seven lines were derived from transgene 2 (isoform II, lines WD-WJ). All expressed very low levels of transcript (data not shown). Only one female derived from transgene 2 developed breast cancer. The dierence in expression between transgene 1 and 2 might be due to the presence of suppressor/silencer sequences in exon 1a. We have noted that Wnt-10b transcripts are normally present in very low abun- 19) , and a tumor-bearing 12 week female following one pregnancy (lanes 20 ± 23), or from a tumor-free 10 week old male (lanes 24 ± 30). The blot was probed with a transgene speci®c probe (Probe B) and exposed to X-ray ®lm for 24 h dance. In addition, all three MMTV insertion events in this locus have occurred between exons 1a and 1b, eectively eliminating exon 1a from viral induced transcripts (Lee et al., 1995; Hardiman et al., 1996) . Because of low levels of transgene 2 expression, these mice were not followed further. Figure 2c shows a blot of RNA isolated from tissues of two 14 week females (lanes 1 ± 19, and 20 ± 23 respectively) and one male (lane 24 ± 30) from line WA. In females, transgene expression was highest in mammary (lanes 1 ± 3) and salivary (lane 4) glands, with low levels detected in the Hardarian/lacrimal gland (lane 5) and skeletal muscle (lane 19). High levels of transgene RNA were also detected in an axillary lymph node (lane 10). MMTV-Wnt-10b females lactate normally and raise their litters. Clonal tumors arising in the mammary glands of a second female also expressed the transgene (lanes 22 and 23), as did tumor-free mammary tissue in this mouse (lanes 20 and 21). A similar pro®le of mammary gland and salivary gland expression was seen in a 14 week male mouse (lanes 24 ± 26). Additional expression was detected in the epidymus/vas deferens (lane 28). Transgene expression appeared absent in the testis (data not shown). This pattern of transgene expression mimics the one observed in other transgenic lines created with the pMMTV promoter construct (Muller et al., 1988) .
Wnt-10b overexpression stimulates ductal branching in transgenic mammary glands
To study the eects of MMTV-Wnt-10b transgene expression, histological preparations of various tissues were analysed. Whole mount preparations of mammary glands from 8 week old wild type FVB/N mice ( Figure 3a ) were compared to age matched transgenic littermates ( Figure 3b ). The mammary glands of MMTV-Wnt-10b transgenic mice showed increased branching with moderate to marked lobulo-alveolar development. During early pregnancy, precocious development of Wnt-10b transgenic glands was even more striking. At d12.5 of pregancy, lobulo-alveolar structures become evident in wild type females ( Figure  3c ). By comparison, age matched transgenic mice (Figure 3d ), have ductal networks that completely ®ll the gland and appear similar to lactating glands. Histological sections of virgin glands showed individual ducts lined with cuboidal epithelium in transgenic mice (compare wild-type, Figure 3e , with transgenic, 3f). Following lactation and 10d of regression, ductal hypertrophy became more evident in Wnt-10b females (compare wild type, Figure 3g , with transgenic, 3h). No consistent changes in morphology were noted in other adult tissues, including the salivary gland and male reproductive tract, where transgene expression was evident (not shown).
MMTV-Wnt-10b mice develop stochastic adenocarcinomas of the breast
Mammary gland tumors developed in all three transgenic lines that carried transgene 1. A cohort of female mice from line WA (n=14) developed disease by 2.5 ± 6 months of age (t 1/2 =104d) ( Figure 4c , closed circles, and Table 1 ). These mice had been bred continuously to induce high level activation of the transgene. However, virgin mice also developed early onset disease, some by 2 months of age (not shown). Signi®cantly, male WA mice also developed tumors ( Figure 4 , ®lled squares, and Table 1 ). In a second line, WC, the founder female developed bilateral mammary tumors at 4 ± 5 months of age and never generated viable ospring. Establishment of line WC required transplantation of ovaries from the founder into wildtype FVB/N females for breeding. WC females produced small litters with few transgenic pups and sometimes appeared to nurse poorly. In a cohort of ®ve WC females, all developed adenocarcinomas of the breast by 6 months ( Figure 4 , open triangles). In combination with the founder, these results indicate that WC transgenic mice were similar to WA mice with respect to the formation of adenocarcinomas (t 1/2 =110 d; n=5) ( Table 1) .
Histological sections from MMTV-Wnt-10b mammary tumors showed development of adenocarcinomas of mixed phenotype (Table 2) . Most Wnt-10b induced week virgin female; (g) wild type female, 10 day of regression following lactation; (h) WA transgenic, 10 day of regression following lactation. Whole amount preparations were stained with carmine red (a ± d), or 5 mm sections were stained with hematoxylin and eosin (e ± h). Arrow heads in a ± b, branch points of secondary mammary ducts. Arrows in b ± d, mammary alveoli. Arrows in e ± h, mammary ducts in cross-section. a, adipocytes; s, lumenal secretions; x, connective tissue stroma. Images were recorded with Nikon photomicroscope. Magnifications: a ± d, Bar=0.5 mm, e ± h, Bar=100 mm tumors fall into the Dunn histological classes found in wild-type mice infected with MMTV (Dunn, 1959; Medina, 1982) . Dunn type A tumors are alveolar carcinomas with a small acinar pattern (Figure 4a ). These are similar to tumors that predominate in MMTV-Wnt-1 transgenic mice (Tsukamoto et al., 1988) . Dunn type B tumors are papillary carcinomas that contain cords of small hyperchromatic cells (Figure 4b ). These are more similar to tumors that predominate in MMTV-FGF-3/int-2 transgenic mice (Muller et al., 1990) . Older mice developed a diuse leukemia with immature myeloid cells in the spleen, and cells with lobulated nuclei in the liver (Table 2) .
In males, Wnt-10b overexpression leads to mammary hyperplasia and aggressive adenocarcinomas Male transgenic mice devloped striking, highly branched, ductal formations in the mammary fat pad (Figure 5b ), while wild type males display rudimentary epithelial buds that rarely develop beyond a few mm in length (Figure 5a ). Histological sections of mammary glands from MMTV-Wnt-10b transgenic males (WA, Figure 5c ) showed a fat pad partially ®lled with mammary ducts and alveoli and often containing cystic ducts ®lled with a clear¯uid. WA males developed mammary adenocarcinomas that were similar to the tumors observed in females (Table 2) , although with delayed kinetics (t 1/2 =395d) (see Figure  4) . The majority of male adenocarcinomas had a small acinar structure (Figure 5d ) typical of Dunn A type tumors in females. MMTV-Wnt-1 transgenic mice also develop feminized mammary tissues, but these do not appear to be as extensive as those identi®ed in MMTVWnt-10b mice (T Lane and P Leder, unpublished results). Nevertheless, it is clear that both transgenes overcome the normal developmental block to mammary duct formation in the male.
Wnt-10b stimulates anchorage-independent growth in tumor derived cell lines
Tumors from all three MMTV-Wnt-10b transgenic lines were passageable by transplantation into FVB/N mice (Table 2 , and data not shown), an indication of transformed tissue. We then established tumor cell lines by serial passage of cells from the primary tumor explants. These cell lines displayed several morphologies, but all grew as monolayers in tissue culture (Figure 6a,c,e) . In addition, all Wnt-10b cell lines displayed anchorage-independent growth, as demonstrated by their ability to grow as colonies in soft agar (Figure 6b,d,f) .
To study growth responsiveness in Wnt-10b tumor cells, we performed soft agar assays. Dishes were treated with dexamethasone (a potent stimulator of the (Chooi et al., 1994; Kwan et al., 1992) (Lee et al., 1995) (Muller et al., 1990) Present Study a Line identi®cation codes (WX) refer to mice derived from individual transgenic founder animals.
b
Age refers to 50% tumor free survival, T (days) MMTV promoter) (Huang et al., 1981) or vehicle alone (DMSO diluted 1 : 5000 in growth medium). In MMTV-Wnt-10b bearing WC3F cells (Figure 6e and f), colony number was stimulated 79% in dishes treated with 1610
77 M dexamethasone and 62% in dishes treated with 1610 76 M dexamethasone (Figure 6g ). This increase was signi®cantly greater than the induction observed with EGF (30%), or TGF-b (no signi®cant dierence) under the same conditions (Figure 6g ). Similar dexamethasone-dependent growth was seen for all Wnt-10b tumor-derived cell lines studied to date (n=3, not shown). Non-transgenic mouse mammary cell lines (HC11, (Ball et al., 1988) ) that have a defective p53 gene, grew poorly in soft agar and colony number was not stimulated by dexamethasone (not shown). By RNA blot analysis, Wnt-10b transgene mRNA increased 30-fold following stimulation with 1610 77 M dexamethasone providing evidence that the increase in colony number was dependent on transgene expression (not shown). These results indicate that Wnt-10b expression has a direct eect on anchorge-independent growth, a measure of cellular transformation.
Because Wnt-10b was discovered through its apparent collaboration with a member of the FGF family (Lee et al., 1995) , we wished to see whether Wnt10b expressing cells responded to FGF growth stimulation. Therefore, we tested the response of WC3F (expressing MMTV-Wnt-10b) and NX1128 (expressing MMTV-FGF-3/int2) cells to FGF-2/bFGF and FGF-7/KGF. FGF-2/bFGF is thought to act through mulitple FGF receptors, whereas FGF-7/KGF appears to bind speci®cally to IIIb isoforms of Fgf receptor 1 (FgfR1) and FgfR2 (Mathieu et al., 1995) . Interestingly, WC3F cells responded to FGF-2/bFGF ( Figure 7 , column 2), but not to FGF-7/KGF (column 3). Conversely, NX1128 cells responded to FGF-7/KGF, but not to FGF-2/bFGF (columns 7 and 6, respectively). Both lines responded similarly to stimulation with epidermal growth factor (EGF; columns 4 and 8). These results support the hypothesis that proliferation of MMTV-Wnt-10b-expressing cells could be enhanced by stimulation with speci®c FGF family members. Interaction of Wnt-10b with FGF-3/int-2 Because of the potential for collaboration between Wnt-10b and FGF-3/int-2 (Lee et al., 1995), we asked whether Wnt-10b would require the proliferative action of an FGF family member in tumor formation by testing for the production of various FGFs in a panel of Wnt-10b tumors and tumor-derived cell lines. We used RNAse protection assays to detect transcripts of FGF-1/aFGF, FGF-2/bFGF, FGF-3/int-2, FGF-4/hst, FGF-5, FGF-7/KGF, FGF-8 and the FGF-receptor 1 (FgfR1). Wnt-10b-derived tumors and tumor-derived cell lines expressed FGF-1/aFGF, FGF-2/bFGF and FgfR1 (FGF receptor 1) (data not shown). FGF-3/int-2, FGF-4/hst, FGF-5 or FGF-7/KGF mRNAs were not detected. All cells tested expressed constitutive levels of FGF-1/aFGF, FGF-2/bFGF, FGF-8 and FgfR1, indicating that production of these FGFs, or others not tested for, could play a role in any response, to Wnt expression.
Since we expected simultaneous induction of Wnt10b and a member of the FGF family to have potent eects on mammary growth, we wished to assess the interaction of such genes in vivo. By crossing MMTVWnt-10b mice with a line of mice that overexpress FGF-3 (Muller et al., 1990) , we hoped to study the interaction of these genes in the whole animal. However, breeding experiments between MMTVWnt-10b (WA) and MMTV-FGF-3/int-2 (NX) transgenic mice proved dicult to conduct. Very few bitransgenic ospring were generated in WA6NX matings. At present, we have been able to raise three WA6NX bigenic females to sexual maturity. One female developed lymphoma at 4 months. The 5) , 5 ng/ml FGF-2/bFGF (lanes 2 and 6), 5 ng/ml FGF-7/KGF (lanes 3 and 7), 5 ng/ml EGF (lanes 4 and 8). Cells were then stained with crystal violet as described in Materials and methods. Bars represent mean and s.e., n=5 other two were sickly and were sacri®ced at 6 months after being rejected by various mates. To date, no WA6NX mice have produced ospring (three females, two males), implying that the cross is sterile. At this time, mammary transformation has not been detected in these mice. However, analysis of WA6NX mammary tissues showed extensive displasia (Figure 8a and b) . Sections through these glands show hyperplasia (Figure 8c ) that is significantly more extensive than seen with either Wnt-10b and/or FGF-3/int-2 expression alone. While the low numbers of animals make interpretation of the phenoytpe of this cross dicult, it appears that simultaneous overexpression of both Wnt-10b and FGF-3/int-2 in the mammary gland causes very disorganized ductal formation with extensive stromal proliferation.
Discussion
We were interested in understanding the role, if any, that Wnt-10b might play in growth regulation of the mammary gland. Because Wnt-10b is expressed by d12.5 in the embryonic mammary anlagen (Christiansen et al., 1995), we were interested in the possibility that overexpression of this gene would lead to perturbations in growth that would provide evidence of its function. In addition, the method by which Wnt10b was cloned was indicative of a role in transformation (Lee et al., 1995) . Therefore, we were interested additionally in formally testing the hypothesis that Wnt-10b functions as a proto-oncogene in the mammary gland.
To investigate the action of Wnt-10b in mammary development, we studied three lines of transgenic mice engineered to overexpress cDNA isoform I in the mammary epithelium. MMTV-Wnt-10b transgenic female mice bearing isoform I invariably developed ductal hypertrophy accompanied by the premature appearance of alveolar structures (3/3). Glands from Wnt-10b virgin mice were more branched, and had a higher density of ducts, than did nontransgenic littermates. In addition, the ducts were lined with numerous alveoli that were occasionally expanded with uid. This pattern of ductal hypertrophy and precocious alveolar formation was also observed in MMTV-Wnt-1 transgenic mice (Tsukamoto et al., 1988. However, unlike Wnt-1 mice, the mammary epithelium of Wnt-10b mice was functional and females were able to nurse their young. We observed that mammary glands from 8 week old Wnt-10b transgenic mice contained up to twofold more terminal emdbuds than did wild type mammary glands. Taken together with the observed ductal hyperplasia, these results demonstrate that Wnt-10b acted as a growth stimulator in the mammary gland. This activity had the potential to overcome, or suppress, signals that function normally to limit the number and density of ducts in virgin mice (Fauklin and DeOme, 1960) .
Equally important, mammary hypertrophy was also evident in Wnt-10b-transgenic males. Duct formation in males occurred without typical terminal endbuds, or alveolar structures, indicating that the development of such structures is dependent upon additional signals. Among transgenic mice, extensive male mammary hyperplasias appear unique to MMTV-Wnt-10b (present study) and MMTV-Wnt-1 transgenic mice (Tsukamoto et al., 1988) . Even though MMTV-neu, and MMTV-myc/MMTV-TGFa bigenic male mice develop mammary tumors, the mammary epithelium of these males does not expand to ®ll the fat pad to any signi®cant extent (Amundadottir et al., 1996a; and T Lane and P Leder, unpublished data) .
There is little information on the role of Wnt genes in regulating sexual dimorphism. Wingless, a homolog of Wnt-1, is known to collaborate with other genes in the formation of sex combs in male Drosophila (Struhl and Basler, 1993) . In addition, several Wnt genes are regulated dierentially during mammary gland development of mice (Gavin and McMahon, 1992) . Our data make clear that ectopic expression of Wnt-10b in the male mammary rudiment is sucient to overcome the normal limits to ductal development in males. In combination with similar results in Wnt-1 mice Figure 8 MMTV-Wnt-10b6MMTV-FGF-3/int-2 bigenic mice develop disorganized mammary tissues with extensive stroma. Tissues were prepared from a WA6NK female, 16 weeks. (a, b) whole mounts of mammary tissues, (Bar=0.5 mm) (c) paran section of WA6NX mammary tissue (Bar=100 mm). Tissues were prepared and photographed as described in Figure  3 . Arrows, mammary ducts; c, cysts; x, connective tissue stroma (Tsukamoto et al., 1988) , it seems plausible to propose that one function of Wnt genes is to regulate sexually dimorphic development of mammary tissues.
MMTV-Wnt-10b transgenic mice from both sexes displayed a marked predisposition toward the formation of early onset mammary adenocarcinomas (t 1/2 =104 days). Comparable rates of tumor formation, (3 ± 6 months), are observed in relatively few of the oncogene-bearing transgenic mice that have been studied to date. Mice that carry MMTV-Wnt-1 (Tsukamoto et al., 1988) , MMTV-neu (activated) (Muller et al., 1988) , and the WAP-SV40 large T oncogene (Tzeng et al., 1993) all develop tumors in 3 ± 6 months (Table 1) . MMTV-int-3 mice (expressing a truncated Notch 4 gene) and MMTV-polyoma middle T mice are the only singly transgenic mice that present with tumors at signi®cantly earlier times (Amundadottir et al., 1996a) . Wnt-10b transgenic males develop mammary tumors with phenotypes similar to Wnt-10b females although they follow a considerably protracted time course. Male mammary tumors have never been reported in normal FVB/N mice, and appear rare in MMTV transgenic mice bearing a wide variety of oncogenes (Amundadottir et al., 1996a) . Interestingly, male breast tumors have been noted previously in MMTV-Wnt-1 (Tsukamoto et al., 1988) and MMTVneu mice (Muller et al., 1988) .
The comparison of in vivo transforming activities between Wnt-10b and Wnt-1 is of particular interest. Studies that have compared wnt family members for their abilities to transform cells have been carried out largely in tissue culture. These studies have shown that Wnt genes can be placed into at least two functional classes: those that direct transformation of cells, and those that lack this activity (Wong et al., 1994; Bradbury et al., 1994) . Additionally, some Wnt genes appear to have intermediate phenotypes with respect to transformation in vitro. Other groups have noted that such distinctions also apply to the ability of particular Wnt RNAs to induce duplications in the embryonic axis of frogs (Du et al., 1995) . These authors have noted that Wnt genes with strong transforming activity in cultured cells share comparable ability to induce axis formation in frogs, implicating dierences in their molecular targets. One possible explanation for such dierences relates to the ability of individual Wnt genes to interact with speci®c Wnt receptors. The Drosophila frizzled gene has been identi®ed as a wingless receptor (Bhanot et al., 1996) and a large family of related genes has been documented recently in humans . The possibility that individual Wnt proteins might activate dierentially variously expressed frizzled genes, establishes a plausible, and ultimately testable, explanation for their diverse actions on cells.
Our study would support the classi®cation of Wnt10b, along with Wnt-1, and Wnt-3, as genes with the potential of mammary transformation in vivo. This result implies that these genes could use similar or identical modes of signal transduction, including, potentially, the use of speci®c receptor proteins. The observation that Wnt-10b can transform the mammary epithelium also indicates that additional modes of regulation must exist to control the activity of this gene product. Such controls might include regulation of Wnt-10b mRNA synthesis. As noted previously, Wnt10b transcripts appear to be extremely rare in all tissues so far examined (Wang and Shackleford, 1996) , and we observe that transcripts containing exon 1a are transcribed poorly.
A number of Wnt genes are expressed in the mammary gland, where some appear to be regulated by pregnancy-induced hormonal changes (Gavin and McMahon, 1992; Weber-Hall et al., 1994) . Since our previous report demonstrated Wnt-10b mRNA expression in the mammary gland, we looked at the regulation of this transcript through progressive stages of mammary dierentiation and in mammary epithelial cell lines. We identi®ed a single Wnt-10b transcript in mammary tissues of 5 week and 10 week virgin mice. During early pregnancy, Wnt-10b steady state levels decreased relative to other RNAs and were undetectable in late pregnancy and lactation. Low levels of transcripts were observed following postlactational regression of the gland. Transcripts from a variety of gene products follow a pattern of diminished expression during late pregnancy and lactation. However, expression in embryonic and virgin mammary gland, followed by loss during early pregnancy, appears distinct from the pattern of other growth regulatory genes expressed in the epithelial compartment of this tissue, with the exception of Wnt7b (Gavin and McMahon, 1992; Weber-Hall et al., 1994) .
To con®rm that Wnt-10b transcripts were associated with mammary epithelial cells, we examined expression in mammary epithelial cell lines. Expression was observed in mammary epithelial cell lines established from MMTV-myc transgenic mice, and from several established human cell lines (Lane and Leder, unpublished data) . In conjunction with in situ hybridization experiments performed by Christiansen et al. (1995) , these results demonstrate that the mammary epithelium represents a source of expression.
The expression of transcripts from eight distinct Wnt genes has now been examined in mammary tissue (Gavin and McMahon, 1992; Weber-Hall et al., 1994) . Each of these genes appear to be expressed in distinct patterns with respect to cell type and regulation during pregnancy. Gavin and McMahon (1992) observed that Wnt-4 was expressed at high levels in virgin mice and that expression did not diminish signi®cantly during pregnancy. In contrast, they observed that Wnts-5A, -5B and -6 were not detectable in virgin mice, but were dramatically induced during pregnancy. Expression of Wnt-2 has been documented in the myoepithelial compartment in mammary ducts, but is also expressed in fat pads devoid of epithelial cells (BuÈ hler et al., 1993; Weber-Hall et al., 1994) . Similar to Wnt-10b, Wnt-2, -4 and -7b are expressed before pregnancy, and thus have the potential to regulate branching morphogenesis of the gland. In fact, overexpression of Wnt-4 in mammary transplants resulted in hyperplasia and pregnancy-independent alveolar development (Bradbury et al., 1995) . The eects of Wnts-2, -6 and -7b, on development in vivo have not been studied at this time.
Our results establish that Wnt-10b acts as a growth regulator and proto-oncogene in the mammary epithelium of mice. Transformation of the mammary gland was stimulated in parous females, presumably due to transcriptional stimulation of the MMTV-LTR by progesterone (Otten et al., 1988) . Stimulation of the transgene with dexamethasone also had an inductive eect on anchorage-independent growth of MMTVWnt-10b-derived tumor cells in vitro. While Wnt-10b over-expression resulted in hyperplasia in all mammary tissues in transgenic mice, transformation occurred in a stochastic fashion. This result implicates a need to acquire additional mutations prior to transformation, and conversely, that elevated Wnt-10b expression predisposes to, but is not sucient for, mammary transformation.
Previous studies have implicated genes of the FGF family as collaborative partners in Wnt mediated transformation (Kwan et al., 1992; Shackleford et al., 1993; MacArthur et al., 1995) . We originally identi®ed Wnt-10b from a screen for genes that would amplify the transforming signal of FGF-3/int-2 (Lee et al., 1995) . When Wnt-10b mice were mated with mice carrying MMTV-FGF-3/int-2, bigenic ospring were sickly and produced very disorganized mammary epithelium. This result, in itself, does not directly con®rm the expectation that Wnt-10b and FGF-3/int-2 would collaborate in transformation. However, it does indicate that these genes interact dramatically to disrupt normal development when overexpressed in the same tissue. In addition, FGF proteins had potent proliferative eects on Wnt-10b-derived tumor cell lines. The proliferative actions of FGFs could indicate, in part, a mechanism for the potent collaborative eect of FGFs when co-expressed with members of the Wnt family, in the induction of mammary tumors in mice.
Continued work on systems such as the mammary gland, in which the eects of growth regulatory genes can be manipulated and studied, will be required to elucidate the mechanism by which individual Wnt genes regulate growth in vivo. Our results demonstrate that overexpression of Wnt-10b can in¯uence the density and branching of mammary ducts, and can stimulate pregnancy independent alveolar formation. The expanded mammary tissues of MMTV-Wnt-10b transgenic mice are functional, indicating that the overgrowth is regulated, and/or compensated, by other genes present in this tissue. However, since endogenous Wnt-10b transcripts decrease in early pregnancy it is likely that the normal role of this gene lies in the establishment of ductal branching and alveolar outgrowth at the earliest stages of mammary development. Tight control of Wnt-10b expression appears important to prevent overgrowth and/or transformation.
Materials and methods

Generation of MMTV-Wnt-10b transgenic mice
Four Wnt-10b cDNA clones were isolated from a 17 day mouse embryo cDNA library (Stratagene). Positive clones were plaque puri®ed and inserts subcloned into the EcoRI site of pBS-KSII (Stratagene) prior to complete double stranded sequencing (Sequenase TM , USB). Clone pBS-F9s (isoform I) and clone pBS-F4 (isoform II) contained identical coding sequences, but distinct 5' and 3' noncoding regions. To verify that each clone contained sucient information to encode protein, clones were translated into protein using in vitro translation reactions (Invitrogen). Products of in vitro translation reactions were resolved on SDS ± PAGE minigels, using 4% stacking and 12% separating gels.
35 S-labeled proteins were then visualized by autoradiography on standard X-ray ®lm.
pBS-F9s (isoform I) and pBS-F4 (isoform II) were subcloned into the EcoRI site of the MMTV promoter/ enhancer cassette (pMMTV) (Figure 2) (Muller et al., 1988) . The pMMTV vector drives expression of cloned genes under the control of the murine mammary tumor virus-long terminal repeat (MMTV-LTR) and contains an SV40 large T antigen intron and poly-adenylation signal. Regulatory sequences of pMMTV were derived from plasmid PA-9 (Huang et al., 1981) . Before introduction into embryos, nonessential regions of the plasmid were removed by digestion of pMMTV-Wnt-10b clones with SalI and SpeI, and the transgenes were gel puri®ed. DNA fragments were injected into the male pronucleus of one-cell stage of FVB/N inbred mouse embryos. Viable embryos were reimplanted into the oviducts of pseudo-pregnant SW foster mothers and allowed to develop to term.
To identify founder animals, tail DNA was screened by Southern blot analysis for incorporation of the transgene. Founders were tested further for their ability to transmit the transgene to progeny (F1). Three founders (WA, WB, and WC) were identi®ed from embryos injected with transgene 1 (isoform I, F9s). Seven founders (WD, WE, WF, WG, WH, WI, WJ) were identi®ed from embryos injected with transgene 2 (isoform II, F4s). Nine founders passed the transgene. Establishment of the line WC required transplantation of her ovaries to an ovariectomized FVB/N female.
DNA isolation and Southern analysis
DNA was isolated from tails (1 cm) by overnight digestion with proteinase K, 558C (15 mg/ml proteinase K, 10 mM Tris-HCl, pH 7.4, 100 mM NaCl, 50 mM EDTA, 1% SDS). Samples were then diluted with 0.56volume 6 M NaCl, and proteins were precipitated for 15 min, 48C. Debris was spun out and the supernatant (1 ml) injected onto a cushion of EtOH (3 ml). DNA was recovered by spooling, air dried, and resuspended in 150 ml TE (10 mM Tris-HCl, pH 7.6, 1 mM EDTA). For Southern analysis of Wnt-10b transgenes, DNA was digested with BamHI. Digested DNA samples were then resolved on agarose/ TAE gels. Digested DNA samples were then resolved on agarose/TAE gels. Gels were treated with 0.4 N NaOH for 20 min before transfer to nylon membranes (GeneScreen Plus, NEN, Boston, MA). Transferred DNAs were ®xed in place by exposure to u.v. light. Transfers were probed with 32 P-labeled DNA fragments at 428C, in S-buer (48% formamide, 10% dextran sulfate, 4.8% SSC, 100 mM TrisHCl, pH 7.5, 16Denhardt's, 20 mg/ml denatured herring sperm DNA, 1% SDS). Speci®c hybridization was detected by washing the membranes at 628C in 0.1% SSC, 0.1% SDS, and visualizing the hybrids by autoradiography in the presence of intensifying screens. Images were recorded on pre-¯ashed X-ray ®lm (Hyper®lm-MP, Amersham, Arlington Heights, IL). A fragment of the SV40 poly adenylation sequence (probe, Figure 2b ) was used to detect Wnt-10b transgenes.
RNA isolation and blotting
For analysis of the normal expression pattern of Wnt-10b, female Swiss-Webster mice were mated and checked for insemination plugs daily. The morning that followed successful mating was considered to be day 1 post conception. Tumor tissue and tumor cell lines were derived from transgenic mice that are maintained in an FVB/N background. Tissues were isolated and stored frozen (7708C) until use. RNA was isolated by the acidphenol method (RNA Stat-60, Tel-Test`B', Friendswood, TX), with or without additional isolation of poly(A) + RNA using oligo dT-cellulose (Pharmacia, Piscataway, NJ). For RNA blot analysis, heat denatured total RNA (10 mg), or poly(A) + puri®ed RNA (5 mg or 2 mg), was resolved on agarose gels (1.2% agarose containing 0.7% formaldehyde and MOPS-EDTA buer, pH 7.0), then transferred to nylon membranes (GeneScreen Plus, NEN, Boston, MA). Transferred RNA was ®xed to the membranes with u.v. light and residual formaldehyde inactivated by heating to 808C, for 60 min. Hybridization was carried out exactly as described for Southern blots. Probes corresponded to mouse Wnt-10b (probe A, Figure  1 ), or to the SV40 polyadenylation signal (probe B, Figure  2 ). To control for loading, blots were reprobed with a fragment of 28S rRNA (Rich and Steitz, 1987) or the L32 rRNA associated protein (Dudov and Perry, 1984) .
Tissue culture and soft agar assays
Tumor tissue was excised, rinsed in 70% EtOH, and transferred to serum-free DMEM (BioWhittaker, Walkersville, MD) with antibiotics (penicillin, 50 U/ml, and streptomycin, 50 mg/ml, (Gibco BRL, Gaithersburg, MD). Minced tissue was then washed, transferred to fresh culture plates, and epithelial outgrowths were cultured in a 5% CO 2 incubator, 378C. Outgrowth was carried out in DFCI medium (Band and Sager, 1989) to inhibit ®broblast contamination. Established clones were acclimated to growth medium for routine handling (DMEM, 10% bovine calf serum, penicillin, 50 U/ml, streptomycin, 50 mg/ml, and glutamine, 2 mM). Lines were derived by serial passage (1/10) of cells with trypsin/EDTA and clones were selected based on absence of ®broblasts, consistent morphology, and good growth characteristics in culture. NX1128 is a cell line derived from tumors that arose in MMTV-FGF-3/int-2 mice (Muller et al., 1990) and were grown in growth medium. HC11 cells (Ball et al., 1988) (the generous gift of Dr Jerey Rosen) were cultured in growth medium with 5 ng/ml EGF and 10 mg/ml insulin (Sigma).
Anchorage-independent (soft agar) growth assays were carried out by embedding 10610 3 cells in 0.8 ml agar/ DMEM, (®nal concentration, 0.3% agar (Difco, Detroit, MI) as described (Amundadottir et al., 1996b) . Brie¯y, a suspension of lique®ed agar (cooled to 408C) was mixed with cells and plated onto 35 mm tissue culture dishes precoated with a 1 ml cushion of previously polymerized 0.8% agar/DMEM. Soft agar cultures were fed every 3 ± 4 days with DMEM containing 2.5% bovine calf serum, penicillin, 50 U/ml, streptomycin, 50 mg/ml, and glutamine, 2 mM. Treatment of cultures with various growth factors (obtained from Collaborative Research, Bedford, MA) was carried out by direct addition to the growth medium on day 1 and replenishing the treatment every 2 days.
Anchorage-dependent grown assays were conducted by plating 1610 3 cells in wells of 96 well plates (Amundadottir et al., 1996b) . Brie¯y, cells were allowed to attach for 20 h in growth medium and then treated in the presence or absence of various growth regulatory factors. After 3 days, cells were stained with crystal violet (Sigma, 0.5% in 30% MeOH), rinsed with water and dried. Dye was then solubilized in 0.1 M Na 3 C 6 H 5 O 7 in 50% EtOH and absorbance (540 nm) was measured with a u.v. plate reader (Molecular Devices, Sunnyvale, CA).
Histological preparations
Mammary gland whole mounts were prepared by spreading freshly dissected glands (#4) onto glass slides and ®xing in MeCarnoy's (60% MeOH, 30% CHCl 3 , 10% acetic acid) or Tellyesniczky's (70% EtOH : formaldehyde : acetic acid (20 : 1 : 1)) ®xatives for 2 ± 24 h. Glands were then cleared for 1 ± 2 days in acetone, rehydrated in a graded series of ethanol (2 h each), equilibrated in water for 2 h and stained overnight in freshly prepared carmine red solution (1.0 g carmine red and 2.5 g AlK(SO 4 ) 2 in 500 ml H 2 O, heated to 1008C for 20 min, then ®ltered through a Whatman #1 ®lter). Stained glands were washed in tap water (2 h), dehydrated through a graded series of ethanol and transferred to o-methyl salycilate before photography.
Pathological sections were prepared from tissues ®xed in Optimal Fix (American Histological Reagent Co., Lodi, CA) and analysis of paran sections was carried out by Dr Robert Cardi (Transgenic Pathology Laboratory, University of California, Davis, CA).
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